VC Funding Trends for Life Sciences Firms

摘要

Investors Are Spending More Money and Making Higher Valuations. Healthcare venture capitalists have been busy this year, at least their limited partners' dollars have. The numbers have never been better. What does that mean for private biopharmaceu- tical, medical device, and other life science companies seeking funding in 2007? Here's our view of the numbers and trends. Number and Value of VC Investments In the first quarter of 2007, venture cap- ital investors put 2.9 billion dollar into private U.S. healthcare companies, including 1.8 billion dollar in biopharmaceuticals and 953 million dollar in medical device ventures. This represents the largest stakes made in these categories in any quarter since Venture Source and Ernst & Young LLP began quarterly reporting of healthcare funding in 2000.